
Par8o
Total Raised
$13.5MInvestors Count
8Deal Terms
1Funding, Valuation & Revenue
6 Fundings
Par8o has raised $13.5M over 6 rounds.
Par8o's latest funding round was a Acquired - III for on February 2, 2026.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
2/2/2026 | Acquired - III | 3 | ||||
1/1/2022 | Acquired - II | |||||
12/15/2021 | Acquired | |||||
10/8/2015 | Convertible Note | |||||
1/8/2015 | Series A |
Date | 2/2/2026 | 1/1/2022 | 12/15/2021 | 10/8/2015 | 1/8/2015 |
|---|---|---|---|---|---|
Round | Acquired - III | Acquired - II | Acquired | Convertible Note | Series A |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 3 |
Par8o Deal Terms
1 Deal Term
Par8o's deal structure is available for 1 funding round, including their Series A from January 08, 2015.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Par8o Investors
8 Investors
Par8o has 8 investors. NuvemRx invested in Par8o's Acquired - III funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
2/2/2026 | 2/2/2026 | 1 Acquired - III | Corporation | Pennsylvania | ||
Corporation | Utah | |||||
Corporation | Georgia | |||||
Corporation | Minnesota | |||||
Venture Capital | Massachusetts |
First funding | 2/2/2026 | ||||
|---|---|---|---|---|---|
Last Funding | 2/2/2026 | ||||
Investor | |||||
Rounds | 1 Acquired - III | ||||
Board Seats | |||||
Type | Corporation | Corporation | Corporation | Corporation | Venture Capital |
Location | Pennsylvania | Utah | Georgia | Minnesota | Massachusetts |
Compare Par8o to Competitors

Massive Bio operates as an artificial intelligence (AI) driven platform specializing in personalized oncology solutions within the healthcare sector. The company offers services connecting cancer patients and oncologists to clinical trials for new, alternative, and targeted treatments, as well as providing personalized treatment recommendations through a virtual tumor board. It primarily serves the healthcare industry, particularly oncology care providers and cancer patients seeking treatment options. It was founded in 2014 and is based in Istanbul, Turkey.

Judi specializes in clinical trial workflow software within the life sciences sector. The company provides a platform that supports the clinical trials process, allowing for research that meets regulatory standards. Judi's services include support for trial sites, sponsors, CROs, and other partners in the clinical trial ecosystem. It was founded in 2005 and is based in Boston, Massachusetts.

ePHealth specializes in decentralized clinical trials and operates within the healthcare industry. The company offers a clinical trial platform that integrates patient participation, recruiting sites, and coordinating centers, with a focus on trial management and patient enrollment. ePHealth primarily serves the clinical research sector, providing solutions for patients and investigators. It was founded in 2015 and is based in London, United Kingdom.

ObvioHealth is a digital health organization focused on improving clinical trials through technology. The company offers a platform for conducting decentralized and hybrid clinical trials, providing services such as study design, participant recruitment, electronic consent and enrollment, data capture and monitoring, and analytics and reporting. ObvioHealth serves the healthcare sectors, including CROs, medical devices, pharmaceuticals, biotechnology, and consumer health industries. It was founded in 2017 and is based in New York, New York.

Castor operates within the healthcare sector and provides a clinical trial platform designed for the design, deployment, patient engagement, data collection, and analysis of clinical trials. The platform is adaptable and can meet the requirements of different stakeholders in the clinical research process. It primarily serves the healthcare sector. The company was founded in 2012 and is based in Amsterdam, Netherlands.

Hawthorne Effect offers mobile clinical research in the healthcare industry. It provides a technology-driven solution for conducting clinical trials at patients' locations, utilizing a network of healthcare professionals to ensure data quality and compliance. It serves the biopharma sectors by facilitating access to clinical trials and improving patient engagement. It was founded in 2015 and is based in Walnut Creek, California.
Loading...

